查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869638

核酸增幅檢查市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測（2025-2033 年）

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

核酸增幅檢查市場摘要

2024年全球核酸增幅檢查市場規模估計為99.5682億美元，預計到2033年將達到231.4669億美元。

預計從 2025 年到 2033 年，該行業將以 9.30% 的複合年成長率成長。這一成長主要受幾個關鍵因素的驅動，例如感染疾病的日益流行、向照護現場(POC) 的轉變、分子診斷技術的進步、分散式檢查以及對個性化醫療日益成長的需求。

新冠肺炎、肝炎和愛滋病等感染疾病在全球日益加重，凸顯了快速、準確的診斷工具（例如高靈敏度和特異性的核酸增幅檢查）的重要性。此外，即時PCR、等溫擴增方法和自動化系統等持續的技術創新，正在提高臨床和非臨床環境中檢測的效率、速度和可及性。

例如，2023年6月，美國食品藥物管理局（FDA）核准了Cue COVID-19分子檢測試劑盒上市，該試劑盒是一種用於檢測有症狀成年人鼻拭子樣本中SARS-CoV-2病毒遺傳物質的分子核酸擴增檢測（NAAT）試劑盒。值得注意的是，這是第一個經由傳統上市前審查途徑核准的商用家用分子檢測套組（適用於整體呼吸道疾病）。這項突破性進展反映了以患者為中心的診斷模式的轉變，以及家用檢測在公共衛生監測中日益成長的重要性。

此外，核酸增幅檢查（NAAT）的應用範圍正從感染疾病診斷擴展到腫瘤學、基因篩檢和藥物遺傳學等領域，凸顯了其在精準醫療時代的重要性。各國政府和醫療機構也加大對疾病早期檢測計畫和檢查室基礎設施的投入，以促進市場成長。然而，檢測設備高成本、監管複雜以及資源匱乏地區難以取得檢測服務等挑戰，仍是NAAT廣泛應用的主要障礙。

最後，隨著技術創新、醫療保健分散化以及個人化醫療的發展，全球核酸擴增產業預計將穩​​定擴張，進而提升全球診斷能力。在持續的研發投入和完善的法規結構支持下，核酸擴增技術可望在未來十年繼續成為現代分子診斷的基礎。

此外，大規模篩檢計畫的實施和推廣，特別是政府和醫療機構主導的項目，顯著提高了疾病的檢出率和管理水平。這些措施促進了定期體檢和基因檢測，從而推動了核酸擴增技術的廣泛應用。癌症、囊腫纖維化和遺傳性血液疾病等慢性病和遺傳性疾病的日益普遍，促使人們迫切需要精準的分子診斷解決方案，以實現早期發現和標靶治療。

此外，自動化與人工智慧 (AI)、機器學習、機器人技術和微流體等先進技術的融合顯著提高了檢測的靈敏度、通量和結果出具速度。自動化核酸擴增技術 (NAAT) 系統在中心檢查室和照護現場(POC) 環境中正變得越來越實用，因為它們減少了人工干預，降低了人為誤差，並提高了工作流程效用。攜帶式和多重檢測平台的進步正在提高資源匱乏地區分子檢測的可及性。

此外，來自公共衛生機構、國際組織和私人投資者的監管核准和資金籌措舉措正在促進創新和產品商業化。加速法規核准流程、公私合營以及政府對疫情防範的投入，都有助於尖端核酸擴增檢測（NAAT）產品在全球的普及應用。這些因素不僅加強了診斷基礎設施，也為市場的長期成長奠定了基礎。

目錄

第1章核酸增幅檢查市場：調查方法與範圍

第2章核酸增幅檢查市場：執行摘要

  • 市場概述
  • 類型
  • 應用程式簡介
  • 技術概覽
  • 最終用途簡介
  • 競爭格局概覽

第3章核酸增幅檢查市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • 全球季節性流感和通用流感的發生率和嚴重程度都在增加。
    • 感染疾病率增加
    • 分子診斷技術的進展
    • 照護現場(POC) 與分散式檢查的轉變
    • 精準醫療/個人化醫療和基因檢測的需求日益成長
  • 市場限制因素分析
    • 熟練人員短缺和基礎設施有限
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章核酸增幅檢查市場：按類型分類的估計和趨勢分析

  • 核酸增幅檢查市場：按類型分類的差異分析
  • 核酸增幅檢查市場：依檢測方式分類的展望
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 恒溫核酸增幅技術（INAAT）檢測
  • 連接酶鍊式反應 (LCR) 檢測

第5章核酸增幅檢查市場：依應用分類的估計與趨勢分析

  • 核酸增幅檢查市場：依應用分類的差異分析
  • 核酸增幅檢查市場：按應用領域分類的展望
  • 傳染病檢查
    • 新冠病毒檢測
    • 蚊媒疾病檢測
    • 流感檢測
    • 性行為感染傳染病檢測
    • 肝炎檢測
    • 結核病檢測
    • 其他
  • 腫瘤檢測
  • 基因和粒線體疾病檢測
  • 其他

第6章核酸增幅檢查市場：終端使用者需求預測與趨勢分析

  • 核酸增幅檢查市場：終端用途差異分析
  • 核酸增幅檢查市場：依最終用途分類的展望
  • 醫院
  • 中央實驗室和參考實驗室
  • 其他

第7章核酸增幅檢查市場：按地區分類的業務分析

  • 區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品上市
    • 夥伴關係
    • 獲得
    • 合作
    • 資金籌措
  • 主要企業市佔率分析，2024 年
  • 公司熱力圖分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Molbio Diagnostics Limited
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Abbott Laboratories
    • Illumina, Inc.
    • Siemens Healthineers
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
Product Code: GVR-1-68038-388-1

Nucleic Acid Amplification Testing Market Summary

The global nucleic acid amplification testing market size was estimated at USD 9,956.82 million in 2024 and is projected to reach USD 23,146.69 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. This growth is primarily driven by several key factors, including the rising prevalence of infectious diseases, a shift toward point-of-care (POC), advancements in molecular diagnostic technologies, decentralized testing, and the growing demand for personalized medicine.

The rising global burden of infectious diseases such as COVID-19, hepatitis, and HIV continues to underscore the importance of rapid and accurate diagnostic tools like NAAT, which offer high sensitivity and specificity. Moreover, continuous technological innovations, such as real-time PCR, isothermal amplification methods, and automated systems, enhance testing efficiency, speed, and accessibility across clinical and non-clinical settings.

For instance, in June 2023, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test, a molecular NAAT designed to detect SARS-CoV-2 genetic material from nasal swabs in symptomatic adults. Notably, this was the first at-home, over-the-counter molecular test for any respiratory illness to be approved using a traditional premarket review pathway. This milestone reflects the ongoing shift toward patient-centered diagnostics and the growing importance of home-based testing in public health surveillance.

Furthermore, the use of NAAT is expanding beyond infectious disease diagnostics to oncology, genetic screening, and pharmacogenomics, highlighting its importance in the era of precision medicine. Governments and healthcare organizations are also investing in early disease detection programs and laboratory infrastructure to help drive market growth. However, challenges such as high testing equipment costs, regulatory complexities, and limited access in low-resource settings continue to impede widespread adoption.

Finally, the global nucleic acid amplification industry is expected to expand steadily as technological innovation, healthcare decentralization, and the pursuit of personalized medicine work together to improve diagnostic capabilities around the world. With continued R&D investment and supportive regulatory frameworks, NAAT is expected to remain a cornerstone of modern molecular diagnostics for the next decade.

Furthermore, increasing awareness and implementing large-scale screening programs, particularly those initiated by governments and healthcare organizations, significantly improves disease detection and management. These initiatives promote regular health check-ups and genetic testing, which increases the use of nucleic acid amplification technologies. The rising prevalence of chronic and genetic disorders, such as cancer, cystic fibrosis, and hereditary blood diseases, has increased the need for precise molecular diagnostic solutions that allow for early detection and targeted treatment planning.

Moreover, the integration of advanced technologies and automation such as artificial intelligence (AI), machine learning, robotics, and microfluidics has significantly improved test sensitivity, throughput, and turnaround time. Automated NAAT systems reduce manual intervention, reduce human error, and improve workflow efficiency, making them more useful in both centralized laboratories and point-of-care (POC) settings. The advancement of portable and multiplexed platforms is increasing the accessibility of molecular testing to resource-constrained regions.

Furthermore, regulatory approvals and funding initiatives by public health authorities, international organizations, and private investors encourage innovation and product commercialization. Accelerated regulatory pathways, public-private partnerships, and government investments in pandemic preparedness have all helped to increase the global availability of cutting-edge NAAT products. These combined factors not only enhance diagnostic infrastructure but also lay the groundwork for long-term market growth.

Global Nucleic Acid Amplification Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nucleic acid amplification testing market based on type, application, technology, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymerase Chain Reaction (PCR) Tests
  • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • Ligase Chain Reaction (LCR) Tests
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Disease Testing
    • COVID-19 Testing
    • Mosquito-Borne Disease Testing
    • Influenza Testing
    • Sexually Transmitted Infections Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Others
  • Oncology Testing
  • Genetic & Mitochondrial Disease Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Central and Reference Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Nucleic Acid Amplification Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type
      • 1.1.1.2. Application Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Influenza Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Nucleic Acid Amplification Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type
  • 2.3. Application Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increasing global prevalence and severity of seasonal and zoonotic influenza outbreaks
    • 3.4.2. Rising prevalence of infectious diseases
    • 3.4.3. Advancements in molecular diagnostic technologies
    • 3.4.4. Shift toward point-of-care (POC) and decentralized testing
    • 3.4.5. Growing demand for precision/personalized medicine and genetic diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Shortage of skilled personnel and infrastructure limitations
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Nucleic Acid Amplification Testing Market: Type Estimates & Trend Analysis

  • 4.1. Nucleic Acid Amplification Testing Market: Type Movement Analysis
  • 4.2. Nucleic Acid Amplification Testing Market by Test Outlook (USD Million)
  • 4.3. Polymerase Chain Reaction (PCR) Tests
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Ligase Chain Reaction (LCR) Tests
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Nucleic Acid Amplification Testing Market: Application Estimates & Trend Analysis

  • 5.1. Nucleic Acid Amplification Testing Market: Application Movement Analysis
  • 5.2. Nucleic Acid Amplification Testing Market by Application Outlook (USD Million)
  • 5.3. Infectious Disease Testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. COVID-19 Testing
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Mosquito-Borne Disease Testing
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Influenza Testing
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Sexually Transmitted Infections Testing
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.6. Hepatitis Testing
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.7. Tuberculosis Testing
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.8. Others
      • 5.3.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Oncology Testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Genetic & Mitochondrial Disease Testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Nucleic Acid Amplification Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Nucleic Acid Amplification Testing Market: End Use Movement Analysis
  • 6.2. Nucleic Acid Amplification Testing Market by End use Outlook (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Central And Reference Laboratories
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Nucleic Acid Amplification Testing Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Nucleic Acid Amplification Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. F. Hoffmann-La Roche Ltd
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Molbio Diagnostics Limited
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Becton, Dickinson and Company
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Danaher Corporation
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Abbott Laboratories
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Illumina, Inc.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Siemens Healthineers
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. bioMerieux SA
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Bio-Rad Laboratories, Inc.
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Seegene Inc.
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Nucleic Acid Amplification Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 UK Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Germany Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 France Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Italy Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Spain Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Sweden Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Sweden Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Norway Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Norway Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Norway Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Denmark Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Denmark Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 Denmark Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Japan Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 China Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 India Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Australia Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Thailand Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 South Korea Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 South Korea Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 South Korea Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 MEA Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 MEA Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 82 MEA Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 83 MEA Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Africa Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 91 UAE Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 92 UAE Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Nucleic Acid Amplification Testing Market - Key market driver analysis
  • Fig. 7 Global Nucleic Acid Amplification Testing Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Nucleic Acid Amplification Testing Market - Porter's analysis
  • Fig. 10 Global Nucleic Acid Amplification Testing Market - PESTEL analysis
  • Fig. 11 Global Nucleic Acid Amplification Testing Market: Type outlook key takeaways
  • Fig. 12 Global Nucleic Acid Amplification Testing Market: Type movement analysis
  • Fig. 13 Polymerase Chain Reaction (PCR) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Ligase Chain Reaction (LCR) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Nucleic Acid Amplification Testing Market Application Outlook Key Takeaways
  • Fig. 17 Global Nucleic Acid Amplification Testing Market: Application movement analysis
  • Fig. 18 Infectious Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 COVID-19 Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Mosquito-Borne Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Sexually Transmitted Infections Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Hepatitis Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Tuberculosis Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Others Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Oncology Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Genetic & Mitochondrial Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Others Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Global Nucleic Acid Amplification Testing Market: End Use Outlook Key Takeaways
  • Fig. 29 Global Nucleic Acid Amplification Testing Market: End Use movement analysis
  • Fig. 30 Hospitals Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Central And Reference Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Global Nucleic Acid Amplification Testing Market: Regional movement analysis
  • Fig. 35 North America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 36 US Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 37 Canada Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 39 Europe Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 40 UK Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 41 Germany Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 42 France Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 48 Asia Pacific Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 49 Japan Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 50 China Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 51 India Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 53 Australia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 54 Thailand Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 55 Latin America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 56 Brazil Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 57 Argentina Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 58 MEA Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 59 South Africa Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 61 UAE Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 62 Kuwait Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 63 Strategy framework